Physician profile
Christopher Moon
NPI 1043221443
$611.06
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $68.36 · 2022: $139 · 2023: $56.88 · 2024: $84.38 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $148.34 | 2021-2025 | Easyfuse |
| Depuy Synthes Sales INC. | $138.76 | 2023-2025 | Minibunion, Motoband |
| Paragon 28, INC. | $127.39 | 2019-2024 | Precision Guide Lapidus |
| Smith+Nephew, INC. | $42.63 | 2021-2022 | |
| Djo, LLC | $37.72 | 2022-2024 | Cmf |
| Paratek Pharmaceuticals, INC. | $33.80 | 2025 | Nuzyra |
| Orthofix Medical, INC. | $33.30 | 2023-2025 | Physio-Stim |
| Averitas Pharma INC. | $14.18 | 2023 | Qutenza |
| Trilliant Surgical LLC. | $13.86 | 2022 | |
| Abbott Laboratories | $11.05 | 2021 | |
| Triad Life Sciences INC. | $10.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.